Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia
Titel:
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia
Auteur:
Barr, Paul M. Owen, Carolyn Robak, Tadeusz Tedeschi, Alessandra Bairey, Osnat Burger, Jan A. Hillmen, Peter Coutre, Steve E. Dearden, Claire Grosicki, Sebastian McCarthy, Helen Li, Jian-Yong Offner, Fritz Moreno, Carol Zhou, Cathy Hsu, Emily Szoke, Anita Kipps, Thomas J. Ghia, Paolo